Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
FDA Orange Book
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Aerosol Ot
2. Colace
3. Deh Na Ss
4. Deh-na-ss
5. Diethylhexyl Sodium Sulfosuccinate
6. Dioctyl Sulfosuccinate
7. Dioctyl Sulfosuccinate, Sodium
8. Dioctyl Sulfosuccinates
9. Dioctyl Sulfosuccinic Acid
10. Dioctyl Sulfosuccinic Acid, Ammonium Salt
11. Dioctyl Sulfosuccinic Acid, Barium Salt
12. Dioctyl Sulfosuccinic Acid, Calcium Salt
13. Dioctyl Sulfosuccinic Acid, Magnesium Salt
14. Dioctyl Sulfosuccinic Acid, Potassium Salt
15. Dioctyl Sulfosuccinic Acid, Sodium Salt
16. Dioctylsulfosuccinate
17. Dioctylsulphosuccinate, Sodium
18. Docusate
19. Docusate Calcium
20. Docusate Sodium
21. Doss
22. Sodium Bis(2-ethylhexyl)sulfosuccinate
23. Sodium Dioctyl Sulfosuccinate
24. Sodium Dioctylsulphosuccinate
25. Sodium Sulfosuccinate, Diethylhexyl
26. Sulfosuccinate, Diethylhexyl Sodium
27. Sulfosuccinate, Dioctyl
28. Sulfosuccinates, Dioctyl
29. Sulfosuccinic Acid Bis(2-ethylhexyl) Ester
1. 7491-09-0
2. Rectalad Enema
3. Rectalad
4. Dioctyl Potassium Sulfosuccinate
5. Cik9f54zhr
6. Potassium;1,4-bis(2-ethylhexoxy)-1,4-dioxobutane-2-sulfonate
7. Potassium 1,4-bis(2-ethylhexyl) Sulfosuccinate
8. Butanedioic Acid, Sulfo-, 1,4-bis(2-ethylhexyl) Ester, Potassium Salt
9. Potassium 1,4-bis((2-ethylhexyl)oxy)-1,4-dioxobutane-2-sulfonate
10. Potassium 1,2-bis(2-ethylhexyloxycarbonyl)ethanesulfonate
11. Docusat Kalium
12. Potassium 1,4-bis[(2-ethylhexyl)oxy]-1,4-dioxobutane-2-sulfonate
13. Dioctylkaliumsulfosuccinat
14. Unii-cik9f54zhr
15. Docusate Potassium [usan]
16. Docusate Potassium [usan:usp]
17. Einecs 231-308-5
18. Rectalad Enema (tn)
19. Potassium 1,2-bis(2-ethylhexyloxycarbonyl)ethanesulphonate
20. Docusate Potassium (usp)
21. Ec 231-308-5
22. Schembl61043
23. Docusate Potassium [mi]
24. Chembl2107648
25. Dtxsid60996394
26. Docusate Potassium [vandf]
27. Docusate Potassium [mart.]
28. Docusate Potassium [usp-rs]
29. Docusate Potassium [who-dd]
30. Akos037645443
31. As-60792
32. Docusate Potassium [usp Monograph]
33. Cs-0455423
34. D03886
35. D93009
36. Bis(2-ethylhexyl) Sulfosuccinate Potassium Salt
37. Q27275483
Molecular Weight | 460.7 g/mol |
---|---|
Molecular Formula | C20H37KO7S |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 18 |
Exact Mass | 460.18970617 g/mol |
Monoisotopic Mass | 460.18970617 g/mol |
Topological Polar Surface Area | 118 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 546 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 3 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Surface-Active Agents
Agents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics. (See all compounds classified as Surface-Active Agents.)
Regulatory Info :
Registration Country : Australia
Brand Name : Coloxyl 50
Dosage Form : tablet
Dosage Strength : 50 mg
Packaging : 100
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Waxsol
Dosage Form : ear drops
Dosage Strength : 0.5%
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Related Excipient Companies
Excipients by Applications
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Docusate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Docusate, including repackagers and relabelers. The FDA regulates Docusate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Docusate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Docusate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Docusate supplier is an individual or a company that provides Docusate active pharmaceutical ingredient (API) or Docusate finished formulations upon request. The Docusate suppliers may include Docusate API manufacturers, exporters, distributors and traders.
click here to find a list of Docusate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Docusate DMF (Drug Master File) is a document detailing the whole manufacturing process of Docusate active pharmaceutical ingredient (API) in detail. Different forms of Docusate DMFs exist exist since differing nations have different regulations, such as Docusate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Docusate DMF submitted to regulatory agencies in the US is known as a USDMF. Docusate USDMF includes data on Docusate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Docusate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Docusate suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Docusate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Docusate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Docusate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Docusate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Docusate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Docusate suppliers with NDC on PharmaCompass.
Docusate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Docusate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Docusate GMP manufacturer or Docusate GMP API supplier for your needs.
A Docusate CoA (Certificate of Analysis) is a formal document that attests to Docusate's compliance with Docusate specifications and serves as a tool for batch-level quality control.
Docusate CoA mostly includes findings from lab analyses of a specific batch. For each Docusate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Docusate may be tested according to a variety of international standards, such as European Pharmacopoeia (Docusate EP), Docusate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Docusate USP).
LOOKING FOR A SUPPLIER?